Another at-home COVID-19 test has received FDA authorization, joining hundreds of other at-home tests that have circulated since the pandemic began. Public health experts warn some of them may not be legitimate. Dr. Shad Marvasti, director of Public Health and Prevention at the University of Arizona College of Medicine in Phoenix, is encouraged by the new test. He says accessibility to tests that can deliver rapid results will help people stop the spread of COVID-19. But he is encouraging consumers to do their homework before using any at-home test, even if it's been approved by the FDA.

In a Thursday report developed by nearly two dozen researchers from Arizona State University and University of Arizona Health Sciences, researchers say that Arizona will likely surpass the prior peak of ICU COVID-19 patients as soon as Dec. 18 with holiday travel and by mid-January with current transmission and no increase in holiday travel.

University of Arizona College of Nursing student Jaime Criswell, DNP, is the recipient of the Uniform Advantage-GNSA Scholarship Fund, which supports students who are seeking a master’s or doctoral degree in nursing and are members of the Graduate Nursing Student Academy.

In a press briefing on Wednesday afternoon, Governor Doug Ducey announced COVID-19 testing sites would be added to three Arizona airports. "If it's a PCR test, it's more reliable," said Dr. Shad Marvasti, with the University of Arizona College of Medicine in Phoenix. "But a negative test result by itself again it’s just one snapshot in time."

Ali McBride from the University of Arizona Cancer Center and colleagues discuss a number of topics pertaining to immune thrombocytopenia (ITP), including the diagnosis, clinical manifestations, traditional treatment options, and the advances we’ve seen in the past few years.

How long might immunity to the coronavirus last? Years, maybe even decades, according to a new study – the most hopeful answer yet to a question that has shadowed plans for widespread vaccination. These studies "are all by and large painting the same picture, which is that once you get past those first few critical weeks, the rest of the response looks pretty conventional," said Deepta Bhattacharya, an immunologist at the University of Arizona College of Medicine – Tucson who was not involved in the studies.

A clinical trial at the University of Arizona Health Sciences designed to study the safety and effectiveness of a personalized cancer vaccine in combination with the immunotherapy drug Pembrolizumab will expand its cohort after promising preliminary data was presented at the annual meeting of the Society for the Immunotherapy of Cancer.

Researchers are expanding research showing that creating good sleeping habits can help people quit smoking to focus on smokers who are HIV positive.

An early interest in how the mind works led Dr. Rastogi to specialize in pediatric headaches, a widespread and under-studied health problem.